RANK-L inhibitor as a promising agent for refractory extensive craniofacial fibrous dysplasia: A case report.
Moataz D AbouammoMohammad Bilal AlsavafDaniel M PrevedelloLuma GhalibAlison M BoyceRicardo L CarrauPublished in: Head & neck (2023)
The case highlights the importance and potential efficacy of denosumab in resistant FD management, particularly in cases involving sensitive organs.